By Counterforce Health Team in Kanuma (sebelipase alfa) —

How to Get Kanuma (Sebelipase Alfa) Covered by Cigna in Georgia: Complete Guide with Forms and Appeal Strategies

Answer Box: Getting Kanuma (Sebelipase Alfa) Covered by Cigna in Georgia

Kanuma requires prior authorization from Cigna with documented LAL-D diagnosis via enzyme activity testing and genetic confirmation. The fastest path: 1) Gather LAL enzyme results showing <1.5 nmol/h/mL, 2) Have your doctor submit a complete medical necessity letter through Express Scripts/Accredo, 3) If denied, file internal appeal within 180 days. Georgia residents have external review rights within 60 days of final denial through the Georgia Department of Insurance.

Table of Contents

Set Your Coverage Goal

Your goal is straightforward: get Cigna to approve Kanuma (sebelipase alfa) for lysosomal acid lipase deficiency (LAL-D) through their specialty pharmacy network, typically Express Scripts or Accredo. Success requires meeting specific clinical criteria and partnering effectively with your healthcare provider.

What Cigna Requires for Kanuma Approval

Essential Documentation:

  • LAL enzyme activity test showing markedly reduced activity (<1.5 nmol/h/mL using whole blood or equivalent dried blood spot results)
  • Genetic testing confirming pathogenic LIPA gene mutations
  • Clinical evidence of hepatic dysfunction, dyslipidemia, or other LAL-D manifestations
  • Treatment history documenting inadequate response to supportive therapies
Note: Cigna processes Kanuma through their specialty drug pathway, which means stricter prior authorization requirements and ongoing monitoring for clinical response.

Partnership Strategy with Your Provider

Your doctor needs to demonstrate medical necessity using Cigna's clinical criteria. You'll support this by providing a complete symptom timeline, previous treatment attempts, and functional impact documentation. This collaboration approach significantly improves approval odds.

Prepare for Your Doctor Visit

Symptom Timeline Documentation

Create a chronological record of your LAL-D symptoms:

  • Liver function changes: When ALT/AST elevations first appeared, trends over time
  • Lipid abnormalities: LDL-C levels, HDL-C patterns, triglyceride fluctuations
  • Physical symptoms: Hepatomegaly, abdominal pain, fatigue, growth issues (pediatric patients)
  • Functional impact: Work/school limitations, activity restrictions, quality of life changes

Previous Treatment History

Document all therapies attempted:

  • Lipid-lowering medications: Statins, fibrates, doses, duration, response
  • Dietary modifications: Specific interventions tried, compliance, outcomes
  • Other supportive care: Any liver-directed therapies, supplements, lifestyle changes
  • Reasons for discontinuation: Lack of efficacy, side effects, contraindications

Side Effects and Contraindications

Note any adverse reactions to previous treatments that support the need for Kanuma as the only viable option for LAL-D enzyme replacement therapy.

Build Your Evidence Kit

Laboratory Documentation

Required Test Results:

  • LAL enzyme activity assay from a CLIA-certified laboratory (Mayo Clinic or LabCorp protocols accepted)
  • Genetic testing results showing LIPA gene mutations
  • Liver function tests demonstrating elevated ALT/AST
  • Lipid panels showing characteristic LAL-D patterns (elevated LDL-C, low HDL-C)

Published Guidelines and Evidence

Include references to support medical necessity:

  • FDA labeling for Kanuma in LAL-D treatment
  • Clinical practice guidelines from genetics societies
  • Peer-reviewed studies demonstrating Kanuma's efficacy in LAL-D
Tip: Counterforce Health specializes in turning insurance denials into targeted, evidence-backed appeals by analyzing denial letters and crafting point-by-point rebuttals aligned with payer policies.

Medication History Summary

Prepare a concise table showing:

  • Previous medications tried
  • Doses and duration
  • Clinical response (lab values, symptoms)
  • Reasons for discontinuation

Medical Necessity Letter Structure

Your doctor's medical necessity letter should follow this proven structure:

1. Patient and Diagnosis Information

  • Patient demographics and insurance details
  • ICD-10 codes: E75.5 (Wolman's disease) or E75.6 (other lipid storage disorder)
  • Confirmed LAL-D diagnosis with enzyme activity and genetic results

2. Clinical Rationale

  • Disease severity and progression risk
  • Specific lab values showing LAL deficiency and organ involvement
  • Why Kanuma is uniquely indicated for LAL-D enzyme replacement

3. Previous Treatment Failures

  • Detailed history of supportive therapies attempted
  • Clinical outcomes and reasons for inadequacy
  • Documentation that alternatives cannot address the underlying enzyme deficiency

4. Treatment Plan and Monitoring

  • Dosing per FDA label: Initial 1 mg/kg IV every 2 weeks, with potential escalation
  • Administration site: Hospital outpatient infusion center
  • Monitoring parameters: Liver enzymes, lipid panels, growth metrics
  • Expected outcomes: Improved hepatic function, lipid normalization

5. Supporting References

  • FDA approval documentation
  • Clinical studies demonstrating efficacy
  • Professional society guidelines

Support Your Doctor's Peer-to-Peer Review

If Cigna requests a peer-to-peer review, help your provider prepare:

Offer Scheduling Flexibility

Provide multiple availability windows when your doctor can speak with Cigna's medical director. Peer-to-peer reviews often determine approval outcomes.

Prepare a Concise Case Summary

Create a one-page summary including:

  • Diagnosis confirmation: LAL enzyme results and genetic findings
  • Disease severity: Specific lab abnormalities and clinical manifestations
  • Treatment rationale: Why Kanuma is medically necessary and uniquely effective
  • Monitoring plan: How clinical response will be assessed

Key Talking Points for Your Provider

  • Emphasize LAL-D rarity and lack of alternative enzyme replacement therapies
  • Reference FDA approval and established clinical efficacy
  • Highlight risks of untreated LAL-D progression
  • Discuss expected clinical improvements with Kanuma therapy

After Your Visit: Documentation

Save All Communications

  • Prior authorization submission confirmations
  • Reference numbers for all requests
  • Provider portal messages regarding the case
  • Phone call logs with dates, times, and representatives spoken to

Patient Portal Messaging

Use your healthcare system's patient portal to:

  • Request copies of all documentation submitted to Cigna
  • Ask for updates on prior authorization status
  • Provide additional information if requested by the insurance company

Track Submission Timeline

Document when materials were submitted to maintain awareness of Cigna's response deadlines and your appeal rights.

Respectful Persistence Strategy

Follow-Up Cadence

  • Week 1-2: Allow normal processing time
  • Week 3: Gentle inquiry about status
  • Week 4+: More frequent contact if approaching clinical urgency

Escalation Approach

If initial requests stall:

  1. Request supervisor review within Cigna's utilization management
  2. Ask for expedited processing if clinically appropriate
  3. Involve patient advocacy services if available through your healthcare system

Professional Communication

Maintain courteous, fact-based communication. Document all interactions and focus on medical necessity rather than cost or access arguments.

Cigna Appeals Process in Georgia

Internal Appeals Timeline

Step Deadline Process Form Required
First-Level Appeal 180 days from denial Submit written appeal with clinical documentation Cigna Appeal Form
Second-Level Appeal 180 days from first denial Independent medical review by different reviewer Same form, additional evidence
Expedited Appeal 72 hours decision For urgent medical situations Mark "URGENT" on form

Required Documentation for Appeals

  • Original denial letter or EOB
  • Complete medical records supporting Kanuma necessity
  • Updated clinical information if available
  • Provider attestation of medical necessity

External Review Rights in Georgia

If Cigna denies your internal appeals, Georgia law provides external review rights:

Timeline: File within 60 days of final internal denial Cost: Free to consumer (insurer pays review costs) Decision: Binding on Cigna if overturned Process: Independent medical review by accredited organization

Common Denial Reasons & Solutions

Denial Reason Solution Strategy Required Documentation
Insufficient LAL enzyme documentation Submit validated assay results Mayo Clinic or equivalent CLIA lab report
Lack of genetic confirmation Provide LIPA gene sequencing Pathogenic mutation documentation
Inadequate prior therapy documentation Detail all treatments attempted Medication history with outcomes
Non-formulary status Request formulary exception Medical necessity letter with alternatives analysis
Experimental/investigational claim Provide FDA approval evidence FDA labeling and approval documentation

Addressing Step Therapy Requirements

If Cigna requires step therapy (trying other medications first), document:

  • Clinical contraindications to required medications
  • Previous failures of step therapy requirements
  • Medical urgency preventing delays in appropriate treatment

When to Escalate

Contact Georgia Department of Insurance

File a complaint with the Georgia Office of Insurance and Safety Fire Commissioner if:

  • Cigna violates appeal timelines
  • Proper procedures aren't followed
  • You need assistance with external review process

Consumer Services Hotline: 1-800-656-2298

Additional Support Resources

Georgians for a Healthy Future: Provides consumer assistance with insurance appeals and can offer guidance on navigating the system.

Georgia Legal Services Program: Assists with Medicaid appeals and may provide referrals for commercial insurance issues.

Counterforce Health Note: Counterforce Health helps patients, clinicians, and specialty pharmacies get prescription drugs approved by turning insurance denials into targeted, evidence-backed appeals. Their platform analyzes denial letters and crafts point-by-point rebuttals aligned to each plan's specific rules and requirements.

FAQ

How long does Cigna prior authorization take for Kanuma in Georgia? Standard prior authorization decisions are typically made within 15 business days. Expedited requests for urgent situations may be processed within 72 hours.

What if Kanuma is non-formulary on my Cigna plan? Submit a formulary exception request with medical necessity documentation. Non-formulary status doesn't prevent coverage if medically necessary.

Can I request an expedited appeal for Kanuma? Yes, if delay in treatment would seriously jeopardize your health. Mark all correspondence as "URGENT" and provide clinical justification for expedited processing.

Does step therapy apply if I've tried treatments outside Georgia? Treatment history from any location should count toward step therapy requirements. Provide complete documentation of all previous therapies regardless of where they were tried.

What happens if Cigna denies my external review in Georgia? External review decisions are binding on insurance companies. If approved, Cigna must cover the treatment. If denied, you may consider legal consultation, though administrative remedies are exhausted.

How much does Kanuma cost if I have to pay out-of-pocket? Kanuma is extremely expensive, with annual costs potentially ranging from $890,000 to $4.9 million depending on weight and dosing. Manufacturer assistance programs may be available through Alexion Access Navigator.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Always consult with your healthcare provider and insurance company for specific guidance regarding your situation. Coverage policies and procedures may change; verify current requirements with official sources.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.